Dexamethasone regulation of cFos mRNA in osteoprogenitors

Irena Shur, Rina Socher, Dafna Benayahu

Research output: Contribution to journalArticlepeer-review

Abstract

The glucocorticoid, dexamethasone (Dex), has a beneficial effect on osteogenesis by increasing the activation and differentiation of osteoblastic cells. We investigated the effect of Dex on osteoblasts and detected changes in pattern of expression of cFos mRNA. cFos is an early response gene that is expressed as unspliced and spliced mRNAs. We analyzed the regulation of cFos mRNA in correlation with the cell proliferation status and following the induction by Dex. Treatment of osteoblastic cells with Dex for 30 min resulted in elevated levels of spliced form of cFos mRNA, which was maintained with extended treatment of cultured cells for 24 h. In addition, We demonstrated interaction between glucocorticoid receptor (GR) and cFos mRNA. This study provides evidence for the action of Dex on osteoblasts through dynamic cell responses involving with cFos.

Original languageEnglish
Pages (from-to)240-245
Number of pages6
JournalJournal of Cellular Physiology
Volume202
Issue number1
DOIs
StatePublished - Jan 2005

Fingerprint

Dive into the research topics of 'Dexamethasone regulation of cFos mRNA in osteoprogenitors'. Together they form a unique fingerprint.

Cite this